EF Hutton Acquisition Co. I restated their buy rating on shares of HCW Biologics (NASDAQ:HCWB – Get Rating) in a research note released on Thursday morning, Benzinga reports. The brokerage currently has a $9.00 price objective on the stock. HCW Biologics Stock Down 4.1 % Shares of NASDAQ:HCWB opened at $1.39 on Thursday. The company […]
Related Keywords
, Blackrock Inc , Nasdaq , Ef Hutton Acquisition Co , Hightower Advisors , Biologics Inc , Vanguard Group Inc , Get Rating , Stock Down , Tower Advisors , Vanguard Group , Hcw Biologics , Nasdaq Hcwb , Hcwb , Medical , Reiterated Rating , Ef Hutton Acquisition Co I ,
comparemela.com © 2020. All Rights Reserved.